Sorriso Pharmaceuticals
Developing novel oral antibodies for immune-mediated disease
Sandy, United States · Founded 2020 · $31.0M raised
- Headquarters
- Sandy, Utah
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2C
- Website
- sorrisopharma.com
- Total Funding
- $31.0M
- Last Round
- $31.0M Series ADec 2021
- Rounds
- 1
About
Sorriso Pharmaceuticals is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including Crohn's disease and ulcerative colitis. The company's proprietary oral delivery platform generates potent antibodies that can be administered orally and are designed to maintain therapeutic activity throughout the human intestine. Its lead candidate, SOR102, simultaneously inhibits TNF-alpha and IL-23(p19), two clinically validated drivers of inflammatory bowel disease (IBD). In December 2024, Sorriso announced positive Phase 1b clinical trial results for SOR102 in ulcerative colitis, with data subsequently published in Lancet Gastroenterology & Hepatology and presented at ECCO 2025.
Summary
Sorriso Pharmaceuticals is a Biotech company based in Sandy, United States, founded in 2020. It has raised $31.0M in total across 1 round, most recently a $31.0M Series A round in Dec 2021. Investors include New Enterprise Associates and Arix Bioscience.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2021
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...
Biotechnology company that discovers and develops medicines for serious, life-threatening disease...